Hypertension, Vol 19, 589-594, Copyright © 1992 by American Heart Association
BA Clark, RM Rosa, FH Epstein, JB Young and L Landsberg
Biogenic amine metabolism may be altered in hypertension and thus
contribute to its pathophysiology. This report describes an abnormality in
dopamine excretion in hypertensive subjects in the postabsorptive state
that persists despite an increase in dietary precursors for dopamine
supplied by a protein meal. We studied seven normotensive and six
nonmedicated hypertensive men after two different meals: 60 g protein and a
noncaloric electrolyte-equivalent broth. Overall mean sodium excretion was
56% higher in the hypertensive group throughout both meal studies (p less
than 0.01), implying higher chronic dietary sodium intake. Despite this,
overall urinary excretion of dopamine tended to be lower in hypertensive
than in normotensive subjects (p = 0.06). Hypertensive also differed from
normotensive subjects in their response to protein feeding. In the
normotensive subjects there was a 23% increase in urinary dopamine
excretion (p less than 0.05), which was not seen after the noncaloric meal.
In the hypertensive subjects, there was no change in urinary dopamine after
the protein meal. In the normotensive subjects there was a 74% increase in
sodium excretion (p less than 0.01) after the protein meal, but no
significant change was seen in the hypertensive subjects. There were no
differences in baseline renal plasma flow or glomerular filtration rate
between the groups and no statistically significant differences between the
groups in their renal hemodynamic responses to the meals. In summary,
hypertensive subjects have less renal dopamine production for the amount of
sodium ingested and a decreased renal dopamine production in response to a
protein load as compared with normotensive subjects, consistent with a
renal defect in conversion of DOPA to dopamine.
ARTICLES
Altered dopaminergic responses in hypertension
Department of Medicine, Beth Israel Hospital, Harvard Medical School, Boston, MA 02215.
This article has been cited by other articles:
![]() |
J. He, D. Gu, X. Wu, J. Chen, X. Duan, J. Chen, and P. K. Whelton Effect of Soybean Protein on Blood Pressure: A Randomized, Controlled Trial Ann Intern Med, July 5, 2005; 143(1): 1 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Meneton, X. Jeunemaitre, H. E. de Wardener, and G. A. Macgregor Links Between Dietary Salt Intake, Renal Salt Handling, Blood Pressure, and Cardiovascular Diseases Physiol Rev, April 1, 2005; 85(2): 679 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zeng, H. Sanada, H. Watanabe, G. M. Eisner, R. A. Felder, and P. A. Jose Functional genomics of the dopaminergic system in hypertension Physiol Genomics, November 17, 2004; 19(3): 233 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hussain and M. F. Lokhandwala Renal Dopamine Receptors and Hypertension Experimental Biology and Medicine, February 1, 2003; 228(2): 134 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Kuchel Differential catecholamine responses to protein intake in healthy and hypertensive subjects Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1998; 275(4): R1164 - R1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hussain and M. F. Lokhandwala Renal Dopamine Receptor Function in Hypertension Hypertension, August 1, 1998; 32(2): 187 - 197. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ricci, E. Bronzetti, P. Mulatero, M. Schena, F. Veglio, and F. Amenta Dopamine D3 Receptor in Peripheral Mononuclear Cells of Essential Hypertensives Hypertension, December 1, 1997; 30(6): 1566 - 1571. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |